Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 2.79
SIRO's Cash to Debt is ranked higher than
74% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. SIRO: 2.79 )
SIRO' s 10-Year Cash to Debt Range
Min: 0.05   Max: No Debt
Current: 2.79

Equity to Asset 0.69
SIRO's Equity to Asset is ranked higher than
78% of the 285 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.63 vs. SIRO: 0.69 )
SIRO' s 10-Year Equity to Asset Range
Min: -0.11   Max: 0.88
Current: 0.69

-0.11
0.88
Interest Coverage 53.52
SIRO's Interest Coverage is ranked higher than
77% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.61 vs. SIRO: 53.52 )
SIRO' s 10-Year Interest Coverage Range
Min: 0.96   Max: 9999.99
Current: 53.52

0.96
9999.99
F-Score: 8
Z-Score: 6.09
M-Score: -2.50
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 19.31
SIRO's Operating margin (%) is ranked higher than
90% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.44 vs. SIRO: 19.31 )
SIRO' s 10-Year Operating margin (%) Range
Min: -66.23   Max: 35.85
Current: 19.31

-66.23
35.85
Net-margin (%) 13.32
SIRO's Net-margin (%) is ranked higher than
86% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. SIRO: 13.32 )
SIRO' s 10-Year Net-margin (%) Range
Min: -64.92   Max: 45.97
Current: 13.32

-64.92
45.97
ROE (%) 12.70
SIRO's ROE (%) is ranked higher than
84% of the 283 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. SIRO: 12.70 )
SIRO' s 10-Year ROE (%) Range
Min: -937.01   Max: 106.48
Current: 12.7

-937.01
106.48
ROA (%) 8.44
SIRO's ROA (%) is ranked higher than
85% of the 290 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.24 vs. SIRO: 8.44 )
SIRO' s 10-Year ROA (%) Range
Min: -100.75   Max: 52.3
Current: 8.44

-100.75
52.3
ROC (Joel Greenblatt) (%) 82.32
SIRO's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.38 vs. SIRO: 82.32 )
SIRO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -232.56   Max: 265.09
Current: 82.32

-232.56
265.09
Revenue Growth (%) 12.90
SIRO's Revenue Growth (%) is ranked higher than
87% of the 248 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. SIRO: 12.90 )
SIRO' s 10-Year Revenue Growth (%) Range
Min: -23.4   Max: 80.6
Current: 12.9

-23.4
80.6
EBITDA Growth (%) 10.00
SIRO's EBITDA Growth (%) is ranked higher than
80% of the 210 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.40 vs. SIRO: 10.00 )
SIRO' s 10-Year EBITDA Growth (%) Range
Min: -30.1   Max: 84
Current: 10

-30.1
84
EPS Growth (%) 18.00
SIRO's EPS Growth (%) is ranked higher than
85% of the 220 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. SIRO: 18.00 )
SIRO' s 10-Year EPS Growth (%) Range
Min: -73.5   Max: 263.4
Current: 18

-73.5
263.4
» SIRO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

SIRO Guru Trades in Q1 2013

Paul Tudor Jones 5,400 sh (+58.82%)
Steven Cohen 10,563 sh (+36%)
Manning & Napier Advisors, Inc 233,650 sh (+1.7%)
Ruane Cunniff 2,933,394 sh (+0.36%)
Mariko Gordon 40,539 sh (unchged)
Ron Baron 16,800 sh (unchged)
Columbia Wanger 1,677,266 sh (-1.41%)
Joel Greenblatt 6,703 sh (-4.83%)
Jim Simons 33,100 sh (-68.48%)
» More
Q2 2013

SIRO Guru Trades in Q2 2013

Joel Greenblatt 45,318 sh (+576.09%)
Jim Simons 160,000 sh (+383.38%)
Steven Cohen 24,100 sh (+128.15%)
Paul Tudor Jones 8,300 sh (+53.7%)
Manning & Napier Advisors, Inc 239,950 sh (+2.7%)
Ruane Cunniff 2,955,980 sh (+0.77%)
Ron Baron 16,800 sh (unchged)
Mariko Gordon Sold Out
Columbia Wanger 1,497,000 sh (-10.75%)
» More
Q3 2013

SIRO Guru Trades in Q3 2013

Ron Baron 90,300 sh (+437.5%)
Jim Simons 413,700 sh (+158.56%)
Joel Greenblatt 73,036 sh (+61.16%)
Columbia Wanger 2,126,000 sh (+42.02%)
Manning & Napier Advisors, Inc 241,150 sh (+0.5%)
Steven Cohen Sold Out
Ruane Cunniff 2,954,817 sh (-0.04%)
Paul Tudor Jones 7,100 sh (-14.46%)
» More
Q4 2013

SIRO Guru Trades in Q4 2013

Steven Cohen 6,822 sh (New)
Bill Frels 5,000 sh (New)
Ron Baron 90,300 sh (unchged)
Paul Tudor Jones Sold Out
Columbia Wanger 2,119,000 sh (-0.33%)
Ruane Cunniff 2,931,923 sh (-0.77%)
Manning & Napier Advisors, Inc 233,180 sh (-3.3%)
Jim Simons 189,000 sh (-54.31%)
Joel Greenblatt 12,685 sh (-82.63%)
» More
» Details

Insider Trades

Latest Guru Trades with SIRO

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-12-31 Reduce -82.63%0.13%$66.45 - $72.61 $ 74.297%12685
Joel Greenblatt 2013-09-30 Add 61.16%0.06%$64.77 - $72.3 $ 74.2910%73036
Ron Baron 2013-09-30 Add 437.5%0.02%$64.77 - $72.3 $ 74.2910%90300
Mariko Gordon 2013-06-30 Sold Out 0.15%$62.82 - $75.41 $ 74.295%0
Joel Greenblatt 2013-06-30 Add 576.09%0.11%$62.82 - $75.41 $ 74.295%45318
Joel Greenblatt 2012-12-31 Reduce -20.65%0.01%$55.02 - $63.08 $ 74.2924%7043
Ron Baron 2012-09-30 New Buy0.01%$41.78 - $57.16 $ 74.2951%16800
Lee Ainslie 2012-06-30 Sold Out 0.79%$41.08 - $51.93 $ 74.2959%0
Ruane Cunniff 2012-06-30 Add 15.55%0.15%$41.08 - $51.93 $ 74.2959%2922154
Joel Greenblatt 2012-06-30 New Buy0.04%$41.08 - $51.93 $ 74.2959%11092
Lee Ainslie 2012-03-31 Reduce -40.97%0.45%$43.15 - $52.38 $ 74.2965%1071713
Lee Ainslie 2011-12-31 New Buy1.1%$39.73 - $49.43 $ 74.2969%1815539
Ruane Cunniff 2011-12-31 Add 3995.82%0.94%$39.73 - $49.43 $ 74.2969%2523229
Ruane Cunniff 2011-09-30 New Buy0.03%$39.55 - $56 $ 74.2956%61605
Joel Greenblatt 2011-06-30 Sold Out 0.08%$50.41 - $57.07 $ 74.2940%0
Joel Greenblatt 2011-03-31 New Buy0.08%$40.95 - $52.07 $ 74.2957%5215
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 27.50
SIRO's P/E(ttm) is ranked higher than
56% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.10 vs. SIRO: 27.50 )
SIRO' s 10-Year P/E(ttm) Range
Min: 7.46   Max: 766.86
Current: 27.5

7.46
766.86
P/B 3.30
SIRO's P/B is ranked higher than
54% of the 278 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. SIRO: 3.30 )
SIRO' s 10-Year P/B Range
Min: 0.84   Max: 11.56
Current: 3.3

0.84
11.56
P/S 3.70
SIRO's P/S is ranked lower than
60% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.60 vs. SIRO: 3.70 )
SIRO' s 10-Year P/S Range
Min: 0.74   Max: 7.44
Current: 3.7

0.74
7.44
PFCF 39.70
SIRO's PFCF is ranked lower than
54% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 27.00 vs. SIRO: 39.70 )
SIRO' s 10-Year PFCF Range
Min: 9.29   Max: 99.96
Current: 39.7

9.29
99.96
EV-to-EBIT 17.90
SIRO's EV-to-EBIT is ranked higher than
61% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.32 vs. SIRO: 17.90 )
SIRO' s 10-Year EV-to-EBIT Range
Min: 9.1   Max: 92.6
Current: 17.9

9.1
92.6
PEG 2.40
SIRO's PEG is ranked higher than
60% of the 134 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.13 vs. SIRO: 2.40 )
SIRO' s 10-Year PEG Range
Min: 0.34   Max: 16.43
Current: 2.4

0.34
16.43
Shiller P/E 40.10
SIRO's Shiller P/E is ranked lower than
61% of the 127 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 25.28 vs. SIRO: 40.10 )
SIRO' s 10-Year Shiller P/E Range
Min: 12.2   Max: 337.5
Current: 40.1

12.2
337.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 17.00
SIRO's Price/Tangible Book is ranked lower than
83% of the 232 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. SIRO: 17.00 )
SIRO' s 10-Year Price/Tangible Book Range
Min: 1   Max: 198.23
Current: 17

1
198.23
Price/DCF (Projected) 1.60
SIRO's Price/DCF (Projected) is ranked higher than
62% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. SIRO: 1.60 )
SIRO' s 10-Year Price/DCF (Projected) Range
Min: 0.54   Max: 8.57
Current: 1.6

0.54
8.57
Price/Median PS Value 1.10
SIRO's Price/Median PS Value is ranked higher than
65% of the 268 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. SIRO: 1.10 )
SIRO' s 10-Year Price/Median PS Value Range
Min: 0.04   Max: 2.21
Current: 1.1

0.04
2.21
Price/Peter Lynch Fair Value 2.50
SIRO's Price/Peter Lynch Fair Value is ranked higher than
53% of the 76 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.90 vs. SIRO: 2.50 )
SIRO' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.48   Max: 30.26
Current: 2.5

0.48
30.26
Price/Graham Number 4.50
SIRO's Price/Graham Number is ranked lower than
75% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. SIRO: 4.50 )
SIRO' s 10-Year Price/Graham Number Range
Min: 0.7   Max: 14.32
Current: 4.5

0.7
14.32
Earnings Yield (Greenblatt) 5.60
SIRO's Earnings Yield (Greenblatt) is ranked higher than
65% of the 226 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. SIRO: 5.60 )
SIRO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 10.9
Current: 5.6

1.1
10.9
Forward Rate of Return (Yacktman) 13.68
SIRO's Forward Rate of Return (Yacktman) is ranked higher than
89% of the 217 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. SIRO: 13.68 )
SIRO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -6.2   Max: 53.8
Current: 13.68

-6.2
53.8

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:RXT.Germany
Sirona Dental Systems, Inc. was founded in 1992 and completed an initial public offering of its common stock on July 1, 1997. The Company is a manufacturer of high-quality, technologically-advanced dental equipment, and is focused on developing, manufacturing and marketing innovative solutions for dentists around the world. The Company provides a range of technologically advanced products in each of its four product segments: Dental CAD/CAM Systems; Imaging Systems; Treatment Centers; and Instruments. The Company markets its products globally to dental practices, clinics and laboratories through an international network of distributors. The global dental market encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Recent technological advancements in the dental equipment industry include 3D radiography, digital radiography, CAD/CAM technology, intra oral cameras and periodontal instruments. The market it serves comprises the whole working environment of a dentist or dental technician, including the dentist's chair, lights, imaging systems and dental CAD/CAM systems, instruments, as well as practice furniture and other dental or lab-based systems. Dental CAD/CAM Systems address the worldwide market for dental restorations, which includes several types of restorations, such as inlays, onlays, veneers, crowns, bridges, copings and bridge frameworks made from ceramic, metal or composite blocks. The Company has developed a range of imaging systems for 2D and 3D, panoramic and intra-oral applications that allow the dentist to accommodate the patient in a more efficient manner. Treatment Centers comprise a range of products from basic dentist chairs to sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, as well as specialist centers used in preventative treatment and for training purposes. In July 2008, the Company launched its new TENEO Treatment Center, which combines technology with a timeless design that provides both patient and dentist with the ultimate in convenience and comfort. The Company offers a range of instruments, including handheld and power-operated handpieces for cavity preparation, endodontics, periodontology and prophylaxis. The instruments are supplemented by multi-function tips, supply and suction hoses, as well as care and hygiene systems for instrument preparation. Its product information is actively made available to business publications, dentists, journals, professional organizations and dental schools, and its website. Sirona distributes its products globally to dental practices, clinics and laboratories through an international network of more than 350 distributors. The Company's registered trademarks include, 'Sirona,' 'CEREC,' 'Orthophos,' 'Heliodent,' 'inLab,' 'CDR,' and 'Schick'. It competes with different companies which include large international companies as well as smaller companies that comp

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide